Turn Therapeutics

Calabasas, United States

Turn Therapeutics is a pharmaceutical company that is dedicated to reducing the human and economic costs of infection and skin disease.

$7.0M raised

Mar 2026

Post-IPO Debt

Biotechnology Health Care Medical Medical Device Pharmaceutical

Top Investors

Avenue Capital Group The Global Emerging Markets Group Suriyaa Sundararuban

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Turn Therapeutics

How much funding has Turn Therapeutics raised?

Turn Therapeutics has raised $7.0M in total funding. The most recent round was Post-IPO Debt. The last funding was announced in March 2026.

Who are Turn Therapeutics's investors?

Turn Therapeutics's investors include Avenue Capital Group, The Global Emerging Markets Group, Suriyaa Sundararuban.

Where is Turn Therapeutics headquartered?

Turn Therapeutics is headquartered in Calabasas, United States.

What does Turn Therapeutics do?

Turn Therapeutics is a pharmaceutical company that is dedicated to reducing the human and economic costs of infection and skin disease.

What stage is Turn Therapeutics at?

Turn Therapeutics is at the Post-IPO Debt stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated March 24, 2026.

MLA

"Turn Therapeutics — Funding & Investors." VCBacked, March 24, 2026, https://www.vcbacked.co/company/turn-therapeutics. Accessed July 3, 2026.

APA

VCBacked. (2026). Turn Therapeutics — Funding & Investors. Retrieved July 3, 2026, from https://www.vcbacked.co/company/turn-therapeutics

Wikipedia (cite web)

{{cite web |title=Turn Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/turn-therapeutics |website=VCBacked |access-date=July 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated March 24, 2026.

Similar Companies in Biotechnology

View all

Rapport Therapeutics

Boston$250.0M

Allterum Therapeutics

Houston$1.0M

AlpalifeBio

Woburn$9.8M

Renaissance BioScience

Vancouver$599K

Epsilogen

London$16.3M

Advanced Microbiome Interventions

Amsterdam$300K